KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Jun 27, 2024 | Option Exercise | $2.08 | 25,000 | 52,000 | 168,554 | Jun 28, 2024, 08:30 AM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Mar 04, 2024 | Sale | $41.86 | 3,934 | 164,664 | 143,907 | Mar 04, 2024, 06:12 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Jun 02, 2023 | Option Exercise | $2.08 | 10,000 | 20,800 | 115,035 | Jun 02, 2023, 02:17 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Mar 02, 2023 | Sale | $31.00 | 1,370 | 42,465 | 104,882 | Mar 03, 2023, 04:30 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Oct 21, 2022 | Option Exercise | $2.08 | 10,000 | 20,800 | 81,279 | Oct 24, 2022, 08:00 AM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Oct 17, 2022 | Option Exercise | $2.08 | 10,000 | 20,800 | 71,279 | Oct 17, 2022, 08:12 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | May 03, 2022 | Option Exercise | $2.08 | 20,000 | 41,600 | 60,814 | May 03, 2022, 07:26 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Jan 14, 2022 | Option Exercise | $2.08 | 10,000 | 20,800 | 27,514 | Jan 14, 2022, 05:15 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Jan 12, 2022 | Option Exercise | $2.08 | 15,000 | 31,200 | 32,514 | Jan 14, 2022, 05:01 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Jan 12, 2022 | Sale | $51.85 | 15,000 | 777,684 | 26,087 | Jan 14, 2022, 05:01 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Dec 03, 2021 | Option Exercise | $2.08 | 10,000 | 20,800 | 27,514 | Dec 03, 2021, 06:43 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Dec 03, 2021 | Sale | $53.56 | 10,000 | 535,637 | 19,801 | Dec 03, 2021, 06:43 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Nov 23, 2021 | Option Exercise | $2.08 | 10,000 | 20,800 | 17,256 | Nov 23, 2021, 04:59 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Sep 03, 2021 | Option Exercise | $2.08 | 10,000 | 20,800 | 17,256 | Sep 03, 2021, 05:57 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Sep 03, 2021 | Sale | $60.12 | 10,000 | 601,180 | 8,756 | Sep 03, 2021, 05:57 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Jun 03, 2021 | Option Exercise | $2.08 | 10,000 | 20,800 | 17,256 | Jun 04, 2021, 04:16 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Jun 03, 2021 | Sale | $46.87 | 10,000 | 468,695 | 11,494 | Jun 04, 2021, 04:16 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Apr 13, 2021 | Option Exercise | $2.08 | 7,000 | 14,560 | 7,000 | Apr 13, 2021, 06:37 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Mar 11, 2021 | Option Exercise | $2.08 | 1,805 | 3,754 | 1,805 | Mar 15, 2021, 09:08 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Mar 11, 2021 | Sale | $60.07 | 1,805 | 108,432 | 0 | Mar 15, 2021, 09:08 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Mar 15, 2021 | Option Exercise | $2.08 | 8,195 | 17,046 | 8,195 | Mar 15, 2021, 09:08 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Mar 15, 2021 | Sale | $60.17 | 8,195 | 493,096 | 0 | Mar 15, 2021, 09:08 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Mar 08, 2021 | Sale | $50.65 | 10,000 | 506,470 | 2,301 | Mar 08, 2021, 08:01 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Mar 08, 2021 | Option Exercise | $2.08 | 10,000 | 20,800 | 10,000 | Mar 08, 2021, 08:01 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Mar 03, 2021 | Option Exercise | $2.08 | 20,000 | 41,600 | 20,000 | Mar 05, 2021, 05:26 PM |
KYMR | | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | Mar 03, 2021 | Sale | $44.78 | 20,000 | 895,634 | 13,119 | Mar 05, 2021, 05:26 PM |